200 related articles for article (PubMed ID: 21340468)
21. Behaviorally active doses of the CB1 receptor antagonist SR 141716A increase brain serotonin and dopamine levels and turnover.
Darmani NA; Janoyan JJ; Kumar N; Crim JL
Pharmacol Biochem Behav; 2003 Jul; 75(4):777-87. PubMed ID: 12957219
[TBL] [Abstract][Full Text] [Related]
22. Evidence for both inverse agonism at the cannabinoid CB1 receptor and the lack of an endogenous cannabinoid tone in the rat and guinea-pig isolated ileum myenteric plexus-longitudinal muscle preparation.
Makwana R; Molleman A; Parsons ME
Br J Pharmacol; 2010 Jun; 160(3):615-26. PubMed ID: 20590566
[TBL] [Abstract][Full Text] [Related]
23. (R)-Methanandamide and delta9-tetrahydrocannabinol-induced operant rate decreases in rats are not readily antagonized by SR-141716A.
Järbe TU; Lamb RJ; Liu Q; Makriyannis A
Eur J Pharmacol; 2003 Apr; 466(1-2):121-7. PubMed ID: 12679148
[TBL] [Abstract][Full Text] [Related]
24. CB1 cannabinoid receptors mediate anxiolytic effects: convergent genetic and pharmacological evidence with CB1-specific agents.
Haller J; Varga B; Ledent C; Freund TF
Behav Pharmacol; 2004 Jul; 15(4):299-304. PubMed ID: 15252281
[TBL] [Abstract][Full Text] [Related]
25. Cannabinoid discrimination and antagonism by CB(1) neutral and inverse agonist antagonists.
Kangas BD; Delatte MS; Vemuri VK; Thakur GA; Nikas SP; Subramanian KV; Shukla VG; Makriyannis A; Bergman J
J Pharmacol Exp Ther; 2013 Mar; 344(3):561-7. PubMed ID: 23287700
[TBL] [Abstract][Full Text] [Related]
26. Anxiogenic profile of AM-251, a selective cannabinoid CB1 receptor antagonist, in plus-maze-naïve and plus-maze-experienced mice.
Rodgers RJ; Evans PM; Murphy A
Behav Pharmacol; 2005 Sep; 16(5-6):405-13. PubMed ID: 16148445
[TBL] [Abstract][Full Text] [Related]
27. Sensitization to cocaine is inhibited after intra-accumbal GR103691 or rimonabant, but it is enhanced after co-infusion indicating functional interaction between accumbens D(3) and CB1 receptors.
Ramiro-Fuentes S; Fernandez-Espejo E
Psychopharmacology (Berl); 2011 Apr; 214(4):949-59. PubMed ID: 21128069
[TBL] [Abstract][Full Text] [Related]
28. Involvement of TRPV1 in the Olfactory Bulb in Rimonabant-Induced Olfactory Discrimination Deficit.
Hu SS
Chin J Physiol; 2016 Feb; 59(1):21-32. PubMed ID: 26875559
[TBL] [Abstract][Full Text] [Related]
29. Peripheral selectivity of the novel cannabinoid receptor antagonist TM38837 in healthy subjects.
Klumpers LE; Fridberg M; de Kam ML; Little PB; Jensen NO; Kleinloog HD; Elling CE; van Gerven JM
Br J Clin Pharmacol; 2013 Dec; 76(6):846-57. PubMed ID: 23601084
[TBL] [Abstract][Full Text] [Related]
30. Involvement of cannabinoid CB1 receptors in drug addiction: effects of rimonabant on behavioral responses induced by cocaine.
Filip M; Gołda A; Zaniewska M; McCreary AC; Nowak E; Kolasiewicz W; Przegaliński E
Pharmacol Rep; 2006; 58(6):806-19. PubMed ID: 17220538
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of milk ingestion and growth after administration of a neutral cannabinoid CB1 receptor antagonist on the first postnatal day in the mouse.
Fride E; Braun H; Matan H; Steinberg S; Reggio PH; Seltzman HH
Pediatr Res; 2007 Nov; 62(5):533-6. PubMed ID: 17805201
[TBL] [Abstract][Full Text] [Related]
32. Intra-accumbens rimonabant is rewarding but induces aversion to cocaine in cocaine-treated rats, as does in vivo accumbal cannabinoid CB1 receptor silencing: critical role for glutamate receptors.
Ramiro-Fuentes S; Ortiz O; Moratalla R; Fernandez-Espejo E
Neuroscience; 2010 May; 167(2):205-15. PubMed ID: 20167255
[TBL] [Abstract][Full Text] [Related]
33. Blockade of Nicotine and Cannabinoid Reinforcement and Relapse by a Cannabinoid CB1-Receptor Neutral Antagonist AM4113 and Inverse Agonist Rimonabant in Squirrel Monkeys.
Schindler CW; Redhi GH; Vemuri K; Makriyannis A; Le Foll B; Bergman J; Goldberg SR; Justinova Z
Neuropsychopharmacology; 2016 Aug; 41(9):2283-93. PubMed ID: 26888056
[TBL] [Abstract][Full Text] [Related]
34. Amnesia induced by beta-amyloid fragments is counteracted by cannabinoid CB1 receptor blockade.
Mazzola C; Micale V; Drago F
Eur J Pharmacol; 2003 Sep; 477(3):219-25. PubMed ID: 14522360
[TBL] [Abstract][Full Text] [Related]
35. Grooming, scratching and feeding: role of response competition in acute anorectic response to rimonabant in male rats.
Tallett AJ; Blundell JE; Rodgers RJ
Psychopharmacology (Berl); 2007 Nov; 195(1):27-39. PubMed ID: 17639351
[TBL] [Abstract][Full Text] [Related]
36. Kappa opioid mediation of cannabinoid effects of the potent hallucinogen, salvinorin A, in rodents.
Walentiny DM; Vann RE; Warner JA; King LS; Seltzman HH; Navarro HA; Twine CE; Thomas BF; Gilliam AF; Gilmour BP; Carroll FI; Wiley JL
Psychopharmacology (Berl); 2010 Jun; 210(2):275-84. PubMed ID: 20354680
[TBL] [Abstract][Full Text] [Related]
37. Low dose naloxone attenuates the pruritic but not anorectic response to rimonabant in male rats.
Wright FL; Rodgers RJ
Psychopharmacology (Berl); 2013 Mar; 226(2):415-31. PubMed ID: 23142959
[TBL] [Abstract][Full Text] [Related]
38. Differential effect of opioid and cannabinoid receptor blockade on heroin-seeking reinstatement and cannabinoid substitution in heroin-abstinent rats.
Fattore L; Spano M; Melis V; Fadda P; Fratta W
Br J Pharmacol; 2011 Aug; 163(7):1550-62. PubMed ID: 21518339
[TBL] [Abstract][Full Text] [Related]
39. Effects of rimonabant, a selective cannabinoid CB1 receptor antagonist, in a rat model of Parkinson's disease.
González S; Scorticati C; García-Arencibia M; de Miguel R; Ramos JA; Fernández-Ruiz J
Brain Res; 2006 Feb; 1073-1074():209-19. PubMed ID: 16412990
[TBL] [Abstract][Full Text] [Related]
40. Context-specific reversal of cocaine sensitization by the CB1 cannabinoid receptor antagonist rimonabant.
Gerdeman GL; Schechter JB; French ED
Neuropsychopharmacology; 2008 Oct; 33(11):2747-59. PubMed ID: 18059436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
